Mundipharma dans l'actualité
Distribution mondiale de produits de santé
Tamtam a trouvé 15 articles récents sur Mundipharma.
- Mundipharma to further tap nation's health sector
- Mundipharma announces positive topline results from Phase III ReSPECT trial assessing ▼REZZAYO® (rezafungin) for the prophylaxis of invasive fungal diseases in allogeneic haematopoietic stem cell transplantation patients
- [GPTW] Mundipharma Korea head brings integrity and people-first mindset
- Samjin and Mundipharma will co-supply 2 wound-care dressings to Korean hospitals
- No damages for Glenmark in battle over Mundipharma’s Targin
- Medical Product Alert N°1/2025: Falsified (contaminated) OXYCONTIN 80mg
- In the US, opioid-maker Purdue is bankrupt. Its global counterparts make millions.
- Revealed: How the Sackler family’s opioid empire continues to make hundreds of millions of dollars in profits around the world
- Drugmaker Mundipharma's China unit sale fails to find buyer, sources say
- Mundipharma and Allen & Overy prevail after Glenmark damages claim
- iNova to acquire Mundipharma’s consumer healthcare brands
- Mundipharma, Grünenthal accused of kickbacks in Italy
- Mundipharma inks third biosimilar deal with Celltrion
- Dentons advises Fidelio Healthcare on the acquisition of Mundipharma's production site in Limburg
- City & Mundipharma sign Betadine® partnership
Articles collectés par Tamtam et retenus lorsqu'ils portent sur l'entreprise, des plus récents aux plus anciens. Chacun renvoie à sa source.
Vous vendez à des entreprises comme Mundipharma ?
Tamtam trouve les entreprises qui correspondent à votre client idéal, analyse chaque compte et vous dit qui contacter, et quand.
Trouver des entreprises similaires